A Win for Patients

Published in Government Relations on July 26, 2023

As we approach the effective date of numerous laws passed by the Legislature this year, we want to extend our appreciation to Don Whitney, PAMES, and all those involved in the relentless efforts to get SB 5218 passed. With the dedicated sponsorship of 4th District Sen. Mike Padden, this law marks a significant step forward in making motorized wheelchairs more accessible for everyone. 

Read the announcement below from Sen. Mike Padden's office.

People buying motorized wheelchairs or other mobility-improving equipment will pay less thanks to Senate Bill 5218, which makes such equipment tax-exempt. The Senate and House unanimously approved SB 5218.

“This law will help people with disabilities by removing the sales tax from motorized wheelchairs or other technological equipment, which will help them save money while also helping maintain their independence,” said Padden.

One of the people who provided written testimony in support of SB 5218 is Steve Gleason, a former Gonzaga Prep, Washington State University, and New Orleans Saints football player who contracted amyotrophic lateral sclerosis (ALS), known as Lou Gehrig’s disease.

“This is a huge win for both patients and companies that sell mobility-enhancing equipment, as it removes a barrier that a lot of times made it impossible for patients to get equipment,” said Don Whitney, chief operating officer of Inland Medical and Rehab. “Most insurances, including Medicare, did not pay for the sales tax, leaving either the patient or our company to pay the tax to the state Department of Revenue. In Spokane that is equivalent to 9%. So a $40,000 high-end CRT wheelchair would have a tax of $3,600 that needed to be collected from the patient or our company just absorbed the tax and paid it. We absorbed the cost just so we could service our patients, who are also our friends. In the last decade, over 60 independent companies in Washington state went out of business as they could not maintain paying sales tax and not being reimbursed it.

“My hope is this will help the bottom line for all companies providing services in Washington, leading to patients having more access to service and receiving better equipment. Patients who have to pay privately for this equipment will now also have greater access by not having to pay the tax. Most patients are on limited incomes, and without this equipment may be hospitalized or put into long-term care. The passage of SB 5218 has opened the door for people so they can stay in their homes and has helped companies improve their bottom lines to remain in business and provide quality products and access to service to its patients,” added Whitney.

The new law states that to claim the sales-tax exemption, the purchaser must provide the seller with an exemption certificate as prescribed by the State Department of Revenue. The tax exemption will apply to mobility-enhancing equipment sold or used on or after Aug. 1, 2023.


TAGS

  1. complex rehab
  2. vgm
  3. vgm government

From Our Experts

August Of Action: Your Chance To Connect With Congress thumbnail August Of Action: Your Chance To Connect With Congress It's time to take advantage of August Of Action—a perfect opportunity to make your voice heard. Every summer, federal legislators return to their home states during the Congressional recess. While it gives them a break from Washington D.C., it's primarily a time for them to connect with constituents like you. Proposed Rule Suggests Significant Change To Accreditation Process thumbnail Proposed Rule Suggests Significant Change To Accreditation Process The recently released proposed rule CMS-1828-P contains a significant change that could reshape how suppliers navigate accreditation. The rule proposes a major change that would require suppliers to be surveyed and reaccredited annually instead of the current three (3) year cadence. This proposal raises substantial questions about both operational feasibility and cost implications. HR1 Passes House, Advances to President Trump's Desk for Signature thumbnail HR1 Passes House, Advances to President Trump's Desk for Signature After extensive negotiations and partisan debate, the House has officially passed HR1, clearing the path for the bill to be signed into law by President Donald Trump. The legislation, which aims to reduce federal healthcare expenditures, contains several provisions that may impact the durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) industry. CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program thumbnail CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program On June 30, 2025, CMS filed the anticipated Proposed Rule that includes updates to the Competitive Bidding Program (CBP). Public comments are due 60 days from June 30, 2025. Below is a high-level summary of the rule. It is critical to note that, according to the Proposed Rule Fact Sheet dated June 30, 2025, CMS has stated that they have not announced the specific product categories they are bidding or the specific timeframe for the next competition. Those specifics will be forthcoming in a fu Senate Narrowly Passes HR1, Sending It Back to House for Final Approval thumbnail Senate Narrowly Passes HR1, Sending It Back to House for Final Approval President Donald Trump's sweeping legislative package, formally titled the One Big, Beautiful Bill Act, now referred to as HR1., cleared the Senate today in a dramatic 51–50 vote, with Vice President JD Vance casting the tie-breaking vote. The bill now returns to the House, where lawmakers must decide whether to adopt the Senate's revised version or negotiate further changes before it can reach the president's desk. Several Prominent Medicaid Provisions in Senate's Budget Bill Deemed in Violation of Byrd Rule thumbnail Several Prominent Medicaid Provisions in Senate's Budget Bill Deemed in Violation of Byrd Rule Senate Parliamentarian Elizabeth MacDonough advised this week that multiple Medicaid provisions in the Senate's reconciliation bill would violate Senate procedure by violating the Byrd Rule. The Byrd Rule is a Senate-specific procedural process that allows Senators to prevent or block inclusion of extraneous provisions in reconciliation bills. Other provisions are still under review. Evaluating the Value of a Payer Contract thumbnail Evaluating the Value of a Payer Contract In our last article, Key Payers Denied Your Application Citing Their Network Is Closed – Now What?, we discussed strategies for addressing payer contracting denials due to a closed network. As indicated, this process can be an extremely time-consuming exercise with no guarantees and mixed results. Below are a few things to consider as you evaluate whether a contract is worth the extra effort. Webinar: Webinar: "Navigating The New CMS Landscape: RADs, HMVs, and Supplier Survival" on June 25 at 1 p.m. CT. The Centers for Medicare & Medicaid Services (CMS) has released its final National Coverage Determination (NCD) for RADs and HMVs used in treating chronic respiratory failure due to COPD. While the rule potentially expands access to bilevel ST therapy (RADs), it also introduces complex compliance requirements, tighter usage criteria, and increased documentation burdens—without additional reimbursement.